Biotech Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 August 1, 2022
Biotech Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma August 1, 2022
Biotech Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call August 1, 2022
Biotech Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th August 1, 2022
Biotech Bionano Genomics to Report Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022 August 1, 2022
Biotech Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights August 1, 2022
Biotech Krystal Biotech Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial August 1, 2022
Biotech Immunocore announces upcoming oral presentation of initial Phase 1 data of ImmTAC® candidate IMC-F106C targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022 August 1, 2022